156 related articles for article (PubMed ID: 25453815)
1. Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents.
Shokrzadeh N; Winkler AM; Dirin M; Winkler J
Bioorg Med Chem Lett; 2014 Dec; 24(24):5758-5761. PubMed ID: 25453815
[TBL] [Abstract][Full Text] [Related]
2. Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands.
Dirin M; Urban E; Noe CR; Winkler J
Eur J Med Chem; 2016 Oct; 121():132-142. PubMed ID: 27236069
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic oligonucleotides with polyethylene glycol modifications.
Winkler J
Future Med Chem; 2015; 7(13):1721-31. PubMed ID: 26465713
[TBL] [Abstract][Full Text] [Related]
4. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells.
Vinogradov S; Batrakova E; Li S; Kabanov A
Bioconjug Chem; 1999; 10(5):851-60. PubMed ID: 10502353
[TBL] [Abstract][Full Text] [Related]
5. Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect.
Gaziova Z; Baumann V; Winkler AM; Winkler J
Bioorg Med Chem; 2014 Apr; 22(7):2320-6. PubMed ID: 24613624
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of chimeric oligonucleotides containing phosphodiester, phosphorothioate, and phosphoramidate linkages.
Maier MA; Guzaev AP; Manoharan M
Org Lett; 2000 Jun; 2(13):1819-22. PubMed ID: 10891166
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biophysical properties of tetravalent PEG-conjugated antisense oligonucleotide.
Rahman Chowdhury T; Taufiq T; Ishida K; Ariful Islam M; Kasahara Y; Osawa T; Obika S
Bioorg Med Chem; 2023 Jan; 78():117149. PubMed ID: 36587552
[TBL] [Abstract][Full Text] [Related]
8. Peroxide-mediated desulfurization of phosphorothioate oligonucleotides and its prevention.
Krotz AH; Mehta RC; Hardee GE
J Pharm Sci; 2005 Feb; 94(2):341-52. PubMed ID: 15614814
[TBL] [Abstract][Full Text] [Related]
9. Self-Assembled DNA-PEG Bottlebrushes Enhance Antisense Activity and Pharmacokinetics of Oligonucleotides.
Wang Y; Wang D; Jia F; Miller A; Tan X; Chen P; Zhang L; Lu H; Fang Y; Kang X; Cai J; Ren M; Zhang K
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45830-45837. PubMed ID: 32936615
[TBL] [Abstract][Full Text] [Related]
10. In vitro toxicology and pharmacokinetics of antisense oligonucleotides.
Crooke RM
Anticancer Drug Des; 1991 Dec; 6(6):609-46. PubMed ID: 1772572
[TBL] [Abstract][Full Text] [Related]
11. Labeling of phosphorothioate antisense oligonucleotides with yttrium-90.
Watanabe N; Sawai H; Endo K; Shinozuka K; Ozaki H; Tanada S; Murata H; Sasaki Y
Nucl Med Biol; 1999 Feb; 26(2):239-43. PubMed ID: 10100225
[TBL] [Abstract][Full Text] [Related]
12. PAcM-AN: poly (N-acryloylmorpholine)-conjugated antisense oligonucleotides.
Bonora GM; De Franco AM; Rossin R; Veronese FM; Ferruti P; Plyasunova O; Vorobjev PE; Pyshnyi DV; Komarova NI; Zarytova VF
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1281-8. PubMed ID: 11097058
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oligonucleotides.
Agrawal S; Zhang R
Ciba Found Symp; 1997; 209():60-75; discussion 75-8. PubMed ID: 9383569
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides.
Bonora GM; Ivanova E; Zarytova V; Burcovich B; Veronese FM
Bioconjug Chem; 1997; 8(6):793-7. PubMed ID: 9404651
[TBL] [Abstract][Full Text] [Related]
15. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
Wang S; Lee RJ; Cauchon G; Gorenstein DG; Low PS
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3318-22. PubMed ID: 7724560
[TBL] [Abstract][Full Text] [Related]
16. Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides.
Wang D; Wang Q; Wang Y; Chen P; Lu X; Jia F; Sun Y; Sun T; Zhang L; Che F; He J; Lian L; Morano G; Shen M; Ren M; Dong SS; Zhao JJ; Zhang K
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2113180119. PubMed ID: 35858356
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups.
MacKellar C; Graham D; Will DW; Burgess S; Brown T
Nucleic Acids Res; 1992 Jul; 20(13):3411-7. PubMed ID: 1630912
[TBL] [Abstract][Full Text] [Related]
18. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.
Monia BP; Johnston JF; Sasmor H; Cummins LL
J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854
[TBL] [Abstract][Full Text] [Related]
19. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
[TBL] [Abstract][Full Text] [Related]
20. Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.
Peng Ho S; Livanov V; Zhang W; Li J; Lesher T
Brain Res Mol Brain Res; 1998 Nov; 62(1):1-11. PubMed ID: 9795101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
